Please wait while we open this resource.
K
Medicines & prescribing
CLOPIDOGREL: DRUG INFORMATION
Dr. Reddys
PDF202666 pages417 KB
Clopidogrel is an antiplatelet agent that requires conversion to an active metabolite for its effectiveness. The document highlights the importance of genetic testing for CYP2C19 polymorphisms, which can affect the drug's efficacy. It also includes brand names, dosing recommendations, and considerations for patients requiring anticoagulation therapy. This information is crucial for healthcare providers in managing patients with acute coronary syndrome and other cardiovascular conditions.
Sign in to open
Ask this resource
Answers use this document only.
Your first question is free.
More like this
Resources from the same specialty and type. Curated links will replace these when added.
Clinical Resources
Documents that extend or complement this resource.
Cost Effective Heart Failure Care - St. Mary's Lacor
Same clinical topic · Cardiology
Cardio Oncology Practice Manual A Companion to Braunwalds Heart
Same clinical topic · Cardiology
The Heart-Brain Connection
Same clinical topic · Cardiology
Cardiology in the ER: A Practical Guide
Same clinical topic · Cardiology
NITROGLYCERIN (GLYCERYL TRINITRATE): DRUG INFORMATION
Same clinical topic · Cardiology
SACUBITRIL AND VALSARTAN: DRUG INFORMATION
Same clinical topic · Cardiology
CRITERIA FOR THE DIAGNOSIS OF CARDIOGENIC SHOCK—EUROPEAN PERSPECTIVE: A CLINICAL CONSENSUS STATEMENT
Same specialty · Cardiology
2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
Same specialty · Cardiology
2025 ACC Scientific Statement on the Management of Obesity in Adults With Heart Failure
Same specialty · Cardiology